Pfizer initially turned down the offer of developing a coronavirus vaccine because the company’s top executives thought the virus would be rapidly contained, like Sars…
Home »
BioNTech CEO says vaccine up to 75% effective against India variant
ISTANBUL (Reuters) -BioNTech SE Chief Executive Ugur Sahin said on Thursday the COVID-19 vaccine it developed with Pfizer Inc is expected to be 70% to…
BioNTech CEO says vaccine up to 75% effective against India variant
ISTANBUL (Reuters) -BioNTech SE Chief Executive Ugur Sahin said on Thursday the COVID-19 vaccine it developed with Pfizer Inc is expected to be 70% to…
Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine
The company said its vaccine generated $3.5 billion in revenue in the first three months of this year. By Rebecca Robbins and Peter S. Goodman…
Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status
(Reuters) – Pfizer Inc and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received ‘fast track’ designation from the U.S. health…